Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Rossignol

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Frontiers in Allergy|November 27, 2025
From mechanism to management: CEREMAST perspectives on the intersection of HαT and clonal mast cell disordersLaura Polivka, Olivier Hermine, Julien Rossignol
Brain Sciences|January 1, 2020
Current Therapeutic Strategies for GlioblastomaJulien Rossignol, Bhairavi Srinageshwar, Gary L Dunbar
International Journal of Molecular Sciences|January 28, 2014
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseasesRobert D Wyse, Gary L Dunbar, Julien Rossignol
Brain Sciences|June 26, 2014
Use of Genetically Altered Stem Cells for the Treatment of Huntington's DiseaseAndrew T Crane, Julien Rossignol, Gary L Dunbar
International Journal of Molecular Sciences|February 6, 2016
Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative DiseasesBhairavi Srinageshwar, Panchanan Maiti, Gary L Dunbar, et al.
Leukemia & Lymphoma|June 25, 2011
Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemiaAnne-Sophie Michallet, Julien Rossignol, Bruno Cazin, et al.
Parkinson'S Disease|December 4, 2024
Comparison of the Long-Term Efficacy of Targeting the Subthalamic Nucleus Versus the Globus Pallidus Interna for Deep Brain Stimulation Treatment of Motor Dysfunction in Patients With Parkinson's Disease: A Meta-Analysis StudyMakenna Huhn, Matthew Prewett, Julien Rossignol, et al.
Stem Cells Translational Medicine|January 31, 2020
Prion-like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapyBhairavi Srinageshwar, Robert B Petersen, Gary L Dunbar, et al.
Biomedicines|February 25, 2023
The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot StudyJulien Rossignol, Séverine Hatton, Ashley Ridley, et al.
Behavioral and Cognitive Neuroscience Reviews|June 28, 2006
Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cellsGary L Dunbar, Michael I Sandstrom, Julien Rossignol, et al.
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Frontiers in Allergy|November 27, 2025
From mechanism to management: CEREMAST perspectives on the intersection of HαT and clonal mast cell disordersLaura Polivka, Olivier Hermine, Julien Rossignol
Brain Sciences|January 1, 2020
Current Therapeutic Strategies for GlioblastomaJulien Rossignol, Bhairavi Srinageshwar, Gary L Dunbar
International Journal of Molecular Sciences|January 28, 2014
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseasesRobert D Wyse, Gary L Dunbar, Julien Rossignol
Brain Sciences|June 26, 2014
Use of Genetically Altered Stem Cells for the Treatment of Huntington's DiseaseAndrew T Crane, Julien Rossignol, Gary L Dunbar
International Journal of Molecular Sciences|February 6, 2016
Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative DiseasesBhairavi Srinageshwar, Panchanan Maiti, Gary L Dunbar, et al.
Leukemia & Lymphoma|June 25, 2011
Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemiaAnne-Sophie Michallet, Julien Rossignol, Bruno Cazin, et al.
Parkinson'S Disease|December 4, 2024
Comparison of the Long-Term Efficacy of Targeting the Subthalamic Nucleus Versus the Globus Pallidus Interna for Deep Brain Stimulation Treatment of Motor Dysfunction in Patients With Parkinson's Disease: A Meta-Analysis StudyMakenna Huhn, Matthew Prewett, Julien Rossignol, et al.
Stem Cells Translational Medicine|January 31, 2020
Prion-like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapyBhairavi Srinageshwar, Robert B Petersen, Gary L Dunbar, et al.
Biomedicines|February 25, 2023
The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot StudyJulien Rossignol, Séverine Hatton, Ashley Ridley, et al.
Behavioral and Cognitive Neuroscience Reviews|June 28, 2006
Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cellsGary L Dunbar, Michael I Sandstrom, Julien Rossignol, et al.
Pageof 14